Bio-Techne (TECH) Finished Goods (2010 - 2026)
Bio-Techne (TECH) recorded quarterly Finished Goods of $111.9 million in Q1 2026, down 2.57% quarter-over-quarter from $114.8 million in Q4 2025, and down 1.25% on a YoY basis from $113.3 million in Q1 2025.
Bio-Techne (TECH) Finished Goods (2010 - 2026) Analysis & Trends
Bio-Techne's Finished Goods history runs 16 years deep, the most recent figure standing at $111.9 million for Q1 2026.
- In Q1 2026, Finished Goods fell 1.25% year-over-year to $111.9 million; the TTM figure through Mar 2026 stood at $111.9 million (down 1.25% YoY), while the FY2025 annual figure was $106.2 million, changed 0.11% from the prior year.
- Finished Goods was $111.9 million for Q1 2026 at Bio-Techne, down from $114.8 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $114.9 million in Q3 2025 to a low of $66.9 million in Q2 2022.
- Historically, Finished Goods has averaged $100.4 million across 5 years, with a median of $106.1 million in 2024.
- The sharpest annual moves came in 2023 and 2026: Finished Goods jumped 38.14% in 2023, then declined 1.25% in 2026.
- A 5-year view of Finished Goods shows it stood at $80.5 million in 2022, then gained by 27.76% to $102.9 million in 2023, then gained by 7.04% to $110.2 million in 2024, then increased by 4.26% to $114.8 million in 2025, then retreated by 2.57% to $111.9 million in 2026.
- The last three Finished Goods figures came in at $111.9 million (Q1 2026), $114.8 million (Q4 2025), and $114.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111.89 Mn |
| Dec 31, 2025 | 114.84 Mn |
| Sep 30, 2025 | 114.88 Mn |
| Jun 30, 2025 | 106.19 Mn |
| Mar 31, 2025 | 113.31 Mn |
| Dec 31, 2024 | 110.15 Mn |
| Sep 30, 2024 | 108.81 Mn |
| Jun 30, 2024 | 106.07 Mn |
| Mar 31, 2024 | 104.38 Mn |
| Dec 31, 2023 | 102.91 Mn |
| Sep 30, 2023 | 106.54 Mn |
| Jun 30, 2023 | 92.47 Mn |
| Mar 31, 2023 | 88.04 Mn |
| Dec 31, 2022 | 80.55 Mn |
| Sep 30, 2022 | 78.18 Mn |
| Jun 30, 2022 | 66.94 Mn |
| Jun 30, 2021 | 67.11 Mn |
| Mar 31, 2019 | 56.66 Mn |
| Dec 31, 2018 | 55.65 Mn |
| Sep 30, 2018 | 58.84 Mn |